Format

Send to

Choose Destination
Pharm Res. 2004 Dec;21(12):2213-8.

Aerosol profile extracted from spacers as a determinant of actual dose.

Author information

1
Academic Hospital, Vrije Universiteit Brussel, 1090 Brussels, Belgium. sylvia.verbanck@az.vub.ac.be

Abstract

PURPOSE:

We propose a novel method to evaluate the efficacy of a pressurized metered dose inhaler (pMDI) in combination with a spacer, by not only considering the total dose extractable from the spacer but also the dependence of dose on the volume available for aerosol inhalation.

METHODS:

We studied volume-dependence of aerosol concentration during extraction from two commonly used plastic spacers (150 ml AerochamberPlus; 750 ml Volumatic) after a single puff of a 100 microg salbutamol pMDI (HFA-Ventolin), using laser photometric measurements.

RESULTS:

After a delay of is in each spacer, the aerosol peak dose for AerochamberPlus was 2-fold that for Volumatic (p < 0.001), with the peak appearing well within the first 0.5 L even for the largest spacer. The opposite dose relationship is reached when considering total cumulative dose, which was 2-fold higher for Volumatic than for AerochamberPlus (p < 0.001); >95% of total cumulative dose was extracted well within 3 L for the largest spacer. The 2-fold cumulative dose relationship was confirmed by chemical assay on an absolute filter [AerochamberPlus: 21.4+/-3.2 (SD) microg; Volumatic: 43.8+/-9.1 (SD) microg].

CONCLUSIONS:

Actual aerosol dose available to patients during inhalation via spacers can only be done on the basis of a quantification of aerosol peak dose and cumulative dose as a function of extracted volume.

PMID:
15648252
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center